4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-20-001301
Options or other derivatives
- Director acquired 20,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Avnur Zafrira Director | 2020-05-20 | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | D | ||
Loading xslF345X03/form4-05222020_040515.xml…